SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 103 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,340,000 | +15.4% | 394,587 | -3.5% | 0.00% | 0.0% |
| Q4 2015 | $3,762,000 | +49.0% | 408,913 | +12.4% | 0.00% | 0.0% |
| Q3 2015 | $2,524,000 | -19.1% | 363,736 | +14.5% | 0.00% | 0.0% |
| Q2 2015 | $3,119,000 | +7.7% | 317,535 | -2.8% | 0.00% | 0.0% |
| Q1 2015 | $2,895,000 | +1.2% | 326,705 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,861,000 | +58.1% | 326,705 | +24.4% | 0.00% | – |
| Q3 2014 | $1,810,000 | +31.4% | 262,597 | +0.3% | 0.00% | – |
| Q2 2014 | $1,377,000 | -3.3% | 261,712 | -16.4% | 0.00% | – |
| Q1 2014 | $1,424,000 | -9.8% | 313,012 | 0.0% | 0.00% | – |
| Q4 2013 | $1,578,000 | +13.8% | 313,012 | +14.4% | 0.00% | – |
| Q3 2013 | $1,387,000 | +33.0% | 273,512 | +30.1% | 0.00% | – |
| Q2 2013 | $1,043,000 | – | 210,238 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athos Capital Ltd | 410,389 | $4,596,000 | 3.46% |
| GLG Partners LP | 2,586,437 | $28,968,000 | 1.54% |
| Nine Chapters Capital Management LLC | 32,300 | $362,000 | 0.80% |
| FNY Partners Fund LP | 335,900 | $3,762,000 | 0.64% |
| MENTA CAPITAL LLC | 373,523 | $4,183,000 | 0.61% |
| Yakira Capital Management, Inc. | 85,500 | $958,000 | 0.32% |
| Sapphire Star Partners LP | 18,724 | $209,000 | 0.27% |
| GAM Holding AG | 541,025 | $6,059,000 | 0.26% |
| Bowling Portfolio Management LLC | 127,873 | $1,432,000 | 0.22% |
| Kassirer Asset Management Corp | 15,000 | $168,000 | 0.16% |